Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Sarepta Therapeutics Tumbled Today


On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ: SRPT) stock fell by over 12% today. Investors were displeased with a company update about its fundamentals, and a new share issue.

In separate press releases, Sarepta gave investors a glimpse of its upcoming third-quarter earnings release, and provided details of that share issue.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments